The coagulase activities of various Candida spp were assessed using a classical tube test. A total of 125 clinical Candida isolates representing eight species (C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, C. kefyr, Geotrichum candidum, C. krusei and C. guilliermondii) were incubated with rabbit, sheep or human plasma. After 24 h incubation, 29/64 (45.3%) C. albicans isolates and 23/61 (37.7%) non-albicans Candida strains were positive for coagulase in rabbit plasma, whereas 20/64 (31.2%) C. albicans and 6/61 (9.8%) non-albicans Candida isolates were positive for coagulase in sheep plasma. None of the tested Candida isolates reacted positively in human plasma. These results suggest that rabbit plasma is the most appropriate medium for detection of coagulase activity in Candida spp. Variations in coagulase production by Candida spp may be related to their pathogenicity. It is concluded that the laboratory detection of coagulase activity in clinical isolates of Candida spp may help the diagnosis of Candida-related infections.
Introduction
During recent decades, the incidence of infection with pathogenic fungi has increased dramatically. The most frequently encountered infections are caused by yeast species belonging to the genus Candida, which can cause a wide array of human diseases ranging from superficial mucosal disorders to life-threatening invasive infections. 1 -4 Various characteristics of Candida spp have been proposed as factors that enable this organism to cause disseminated infection in susceptible hosts. For example, the ability to recognize and adhere to host tissues, germ tube and hypha formation, phenotypic switching and thigmotropism, as well as the production of hydrolytic enzymes including lipases and proteases such as secreted aspartyl proteinase, phospholipase, esterases and phosphatases, are all thought to be important in determining virulence. 5 -10 Research on the pathogenicity of Candida spp has focused on enzymes such as proteinases, phospholipases and haemolysins, with only two published studies reporting on coagulase activity. 7, 11 The study presented here is, to our knowledge, the first to analyse the coagulase activity of clinical isolates of Candida spp in different plasmas using the classical coagulase tube test.
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Materials and methods
YEAST STRAINS
The study was carried out using clinical isolates of Candida (isolated from blood, urine, vaginal swabs, wounds and oral cavities) representing eight different species: C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, C. kefyr, Geotrichum candidum, C. krusei and C. guilliermondii. The isolates were identified using standard taxonomic procedures and identification was confirmed by the API 32C AUX identification system for yeasts (bioMérieux, Marcy-l'Etoile, France). The type strains Staphylococcus aureus ATCC 25923 and S. epidermidis ATCC 14990 were used as positive and negative controls, respectively, for coagulase expression.
PLASMA COAGULASE PREPARATION
Rabbit blood was collected by cardiac puncture from healthy adult rabbits from the Medical Practice and Research Centre, Atatürk University. Sheep blood was obtained from a local abattoir. Both types of blood were treated with anticoagulant (disodium ethylenediaminetetraacetic acid) and centrifuged at 8000 g for 30 min at 10°C. The plasmas were then filter-sterilized and samples of the filtrates were placed in screw-cap tubes and frozen at -20°C until used. Human plasma, which had been treated similarly and stored frozen was obtained from the blood bank of Atatürk University Research Hospital.
All procedures in the experimental protocol were approved by the Research Animal Ethics Committee of Atatürk University.
MEASUREMENT OF COAGULASE ACTIVITY
The test strains were cultured overnight in Sabouraud dextrose broth (Oxoid, Cambridge, UK). Approximately 0.1 ml of each culture was then inoculated into tubes containing 500 µl of rabbit, sheep or human plasma. The tubes were incubated at 25, 37 or 45°C and observed for clot formation after 2, 4, 6 and 24 h. 12
Results
A total of 125 clinical isolates of Candida were studied. The coagulase activities of the different species tested after 24 h incubation at 37°C are shown in Table 1 : 29/64 (45.3%) C. albicans isolates and 23/61 (37.7%) non- N Yigit, AE Aktas, A Ayyildiz Detection of coagulase activity in pathogenic Candida species albicans Candida strains were positive for coagulase in rabbit plasma, however only 20/64 (31.2%) C. albicans and 6/61 (9.8%) non-albicans Candida isolates were positive for coagulase in sheep plasma. None of the tested Candida isolates studied reacted positively with human plasma in the coagulase tube test.
The highest coagulase activity was seen with C. albicans strains, which induced clot formation in both rabbit and sheep plasma after 24 h. C. parapsilosis, C. glabrata and C. tropicalis also showed coagulase activity in both types of plasma. C. kefyr, C. guilliermondii, C. krusei and G. candidum strains demonstrated coagulase activity in rabbit plasma but not in sheep plasma.
No differences in the rates of positive coagulase test results were seen between isolates incubated with the various types of plasma at different temperatures (25, 45°C data not shown). In addition, there was no specific relationship between the source of the isolates and coagulase activity (data not shown).
Discussion
It is likely that hydrolytic enzymes expressed on the surface of microbial pathogens are able to cause host cell damage in vivo, but the pathogenic roles of individual enzymes have not yet been elucidated. Most research in Candida spp has focused on proteinases such as secreted aspartyl proteinases, phospholipases and haemolysins; 7 systematic studies involving plasma coagulase are rare. 7, 11 Coagulase production by Candida spp was first reported by Rodrigues et al., 7 who detected high coagulase activity in C. albicans (88.5%) and C. tropicalis (82.6%), but lower activities in other species using the coagulase tube test with rabbit plasma after incubation for 24 h. Positive latex test results were obtained with 68.9% of C. albicans strains, 56.5% of C. tropicalis strains and 6.9% of C. parapsilosis strains, but not with C. glabrata, C. guilliermondii or C. krusei strains. 7 In another study, Becker et al. 11 observed that 40/150 (26.7%) yeast isolates showed positive results in the Pastorex Staph-Plus latex agglutination test.
Coagulase tests are routinely used to detect the presence of S. aureus. The coagulase tube test is the most frequently used method for staphylococci because of its greater accuracy and its ability to detect both bound and free coagulase. 13, 14 Various commercial diagnostic kits such as Pastorex Staph-Plus are also available. Although these are faster than the conventional coagulase test and are apparently more specific, several Candida spp are agglutinated by the reagents used in such tests, lowering the specificity. Rodrigues et al. 7 reported that these results may be due to similarities between the antigens of staphylococci and some yeasts, particularly C. albicans and C. tropicalis.
In the present study, rabbit, sheep and human plasma showed different sensitivities when used to test the coagulase activity of Candida isolates. Rabbit plasma appeared to give the best indication of coagulase activity, whereas sheep plasma was less sensitive and human plasma expressed no activity for any of the Candida spp tested. These data indicate that rabbit plasma is the most appropriate medium for coagulase testing of yeast strains. This observation agrees with those of other researchers who have reported that some strains of S. aureus isolated from humans can clot bovine or sheep plasma as well as human plasma, whereas other S. aureus strains cannot. 15 The lack of staphylocoagulase activity from cows and other animals may be due to the lack of a coagulase-reacting factor, an affinity for 15 Hendrix et al. 16 showed that staphylocoagulase from S. aureus had a highly species-dependent specificity towards human prothrombin compared with bovine prothrombin. Nevertheless, there is no information in the literature on the relative performance of sheep and human plasma in the coagulase tube test for clinical isolates of Candida. Further studies are, therefore, necessary to determine the mechanisms underlying the different coagulase activities of Candida spp in rabbit, sheep and human plasmas.
Coagulase production in Candida spp may be related to pathogenicity. Non-albicans Candida spp have been reported to be less virulent in vitro and in animal models, but have the ability to cause severe infections in humans. 17 Rodrigues et al. 7 demonstrated that the coagulase activities of C. albicans strains were higher than those of other species, and that all C. krusei strains were coagulase negative; Becker et al. 11 reported similar results. The results of the present study are consistent with these findings.
In conclusion, this study demonstrated that the coagulase activities of Candida spp in the tube coagulase test were higher in rabbit plasma than in sheep plasma and were undetectable in human plasma. These results suggest that rabbit plasma is the most appropriate medium for the detection of coagulase activity in Candida spp. In addition, the coagulase activity of Candida spp may be associated with virulence, and warrants further study.
